supplementary figure 1lewis, et al
DESCRIPTION
Cell Death (Ramos). Untreated. Proliferation (Ramos). hIgG (crosslinked). Dacetuzumab (soluble). Dacetuzumab (crosslinked). Percent Cell Death (apoptotic + necrotic). Crosslinking Ab. Dacetuzumab (soluble). hIgG (crosslinked). Dacetuzumab (crosslinked). CD40 Ligand. - PowerPoint PPT PresentationTRANSCRIPT
Supplementary Figure 1 Lewis, et al.
a
b
Da
ce
tuzu
ma
b
(s
olu
ble
)
Da
ce
tuzu
ma
b(c
ross
linke
d)
1 3 10 1 3 10 10 10 20
Un
tre
ate
d
hIg
G (
solu
ble
)
hIg
G (
cro
sslin
ked
)
Cro
ss
lin
kin
g A
bC
D4
0 L
iga
nd
g/ml
phospho-AKT
phospho-ERK1/2 MAPK
IB-
phospho-p38 MAPK
Lane: 1 2 3 4 5 6 7 8 9 10 11
1
Untreated
hIgG (crosslinked)
Dacetuzumab (soluble)
Dacetuzumab (crosslinked)
Cell Death (Ramos)
Pe
rce
nt
Ce
ll D
ea
th
(ap
op
toti
c +
nec
roti
c)
Dacetuzumab (crosslinked)
Proliferation (Ramos)
ng/ml
Dacetuzumab Signaling (RL)
phospho-ERK1/2 MAPK
-Actin
111
ng/ml
Dacetuzumab
Un
trea
ted
333
1.00
x10
3
37.0
12.3
4.12
Ramos
c